Allergy in children: Practical recommendations of the Finnish Allergy Programme 2008-2018 for prevention, diagnosis, and treatment

Pediatric Allergy and Immunology

Volumn 23, Issue 2, 2012, Pages 103-116

  Pelkonen, Anna S ^a   Kuitunen, Mikael ^a   Dunder, Teija ^b   Reijonen, Tiina ^c   Valovirta, Erkka ^d   Mäkelä, Mika J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Allergy; Public health; Tolerance

Indexed keywords

ALLERGEN; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MONTELUKAST; PIMECROLIMUS; PROBIOTIC AGENT; TACROLIMUS;

AIRBORNE PARTICLE; ALLERGIC RHINITIS; ALLERGY; AMBIENT AIR; ASTHMA; ATOPIC DERMATITIS; CHILD WELFARE; CHILDHOOD DISEASE; CLINICAL DECISION MAKING; CONJUNCTIVITIS; CORTICOSTEROID THERAPY; CROSS REACTION; DIET RESTRICTION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; ECZEMA; FINLAND; FOLLOW UP; FOOD ALLERGY; GRAIN ALLERGY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; HUMIDIFIER; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; MEDICAL EDUCATION; MILK ALLERGY; NONHUMAN; NURSE; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT ALLERGY; REVIEW; RISK ASSESSMENT; SENSITIZATION; SMOKING;

CHILD, PRESCHOOL; FINLAND; HUMANS; HYPERSENSITIVITY; PUBLIC HEALTH;

EID: 84858774816     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2012.01298.x     Document Type: Review

References (42)

1. Prescott SL, Smith P, Tang M, et al. The importance of early complementary feeding in the development of oral tolerance: concerns and controversies. Pediatr Allergy Immunol 2008: 19: 375-80.
2. Simpson A, Custovic A. Pets and the development of allergic sensitization. Curr Allergy Asthma Rep 2005: 5: 212-20.
3. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007: 119: 192-8.
4. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008: 122: 788-94 (and a recent review suggested a role for certain probiotics in prevention of atopic eczema).
5. Tang ML, Lahtinen SJ, Boyle RJ. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 2010: 22: 626-34.
6. Siltanen M, Kajosaari M, Poussa T, Saarinen KM, Savilahti E. A dual long-term effect of breastfeeding on atopy in relation to heredity in children at 4years of age. Allergy 2003: 58: 524-30.
7. Osborn DA, Sinn J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev 2003: (4): CD003664.
8. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007: (4): CD006475.
9. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007: (4): 006474.
10. von ME, Braun-Fahrlander C, Schierl R, et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000: 30: 1230-4.
11. von Hertzen LC, Laatikainen T, Pennanen S, Makela MJ, Haahtela T. Is house dust mite monosensitization associated with clinical disease? Allergy 2008: 63: 379-81.
12. Lannero E, Wickman M, van Hage M, et al. Exposure to environmental tobacco smoke and sensitisation in children. Thorax 2008: 63: 172-6.
13. Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999: 103: 717-28.
14. Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol 2001: 108: 881-90.
15. Kim JS, Sampson HA. Food allergy: a glimpse into the inner workings of gut immunology. Curr Opin Gastroenterol 2012: 28: 99-103.
16. Sampson HA. Food-induced anaphylaxis. Novartis Found Symp 2004: 257: 161-71.
17. Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004: 113: 805-19.
18. Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010: 126: S1-58.
19. Burks AW, Jones SM, Boyce JA, et al. NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population. Pediatrics 2011: 128: 955-65.
20. Sampson HA. 9. Food allergy. J Allergy Clin Immunol 2003: 111: S540-7.
21. Koskinen O, Villanen M, Korponay-Szabo I, et al. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. J Pediatr Gastroenterol Nutr 2009: 48: 559-65.
22. Saarinen KM, Pelkonen AS, Mäkelä MJ, Savilahti E. Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status. J Allergy Clin Immunol 2005: 116: 869-75.
23. Cerecedo CI, Dieguez Pastor MC, Bartolome ZB, Sanchez CM, de la Hoz CB. Safety of measles-mumps-rubella vaccine (MMR) in patients allergic to eggs. Allergol Immunopathol (Madr) 2007: 35: 105-9.
24. Mayet A, Ligier C, Gache K, et al. Adverse events following pandemic influenza vaccine Pandemrix(R) reported in the French military forces - 2009-2010. Vaccine 2011: 29: 2576-81.
25. Greer FR, Sicherer SH, Burks AW. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008: 121: 183-91.
26. Hansen KS, Ballmer-Weber BK, Sastre J, et al. Component-resolved in vitro diagnosis of hazelnut allergy in Europe. J Allergy Clin Immunol 2009: 123: 1134-41.
27. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: european Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006: 61: 969-87.
28. Sampson HA. The evaluation and management of food allergy in atopic dermatitis. Clin Dermatol 2003: 21: 183-92.
29. Sears HW, Bailer JW, Yeadon A. Efficacy and safety of hydrocortisone buteprate 0.1% cream in patients with atopic dermatitis. Clin Ther 1997: 19: 710-9.
30. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001: 108: 516-20.
31. Kukkonen K, Savilahti E, Haahtela T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 2008: 122: 8-12.
32. National Asthma Education and Prevention Program. NAEPP expert panel report guidelines - update on selected topics 2007. Available at:.
33. Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008: 63: 5-34.
34. Jauregui I, Davila I, Sastre J, et al. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: the PEDRIAL study. Pediatr Allergy Immunol 2011: 22: 388-92.
35. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010: 126: 466-76.
36. Bornehag CG, Sundell J, Hagerhed-Engman L, et al. 'Dampness' at home and its association with airway, nose, and skin symptoms among 10, 851 preschool children in Sweden: a cross-sectional study. Indoor Air 2005: 15 (Suppl. 10): 48-55.
37. Simpson A, Custovic A. Early pet exposure: friend or foe? Curr Opin Allergy Clin Immunol 2003: 3: 7-14.
38. Simpson A, Custovic A. The role of allergen avoidance in the secondary prevention of atopic disorders. Curr Opin Allergy Clin Immunol 2005: 5: 223-7.
39. Hagerhed-Engman L, Sigsgaard T, Samuelson I, et al. Low home ventilation rate in combination with moldy odor from the building structure increase the risk for allergic symptoms in children. Indoor Air 2009: 19: 184-92.
40. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 2006: 47: 373-80.
41. Asher I, Baena-Cagnani C, Boner A, et al. World Allergy Organization guidelines for prevention of allergy and allergic asthma. Int Arch Allergy Immunol 2004: 135: 83-92.
42. Canonica GW, Bousquet J, Casale T, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009: 64 (Suppl 91): 1-59.